Ashler et Manson (XPAR:MLAEM) EBIT: €0.08 Mil (TTM As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLAEM Ashler et Manson SA XPAR:MLAEM
80 GF Score
Price €3.04
GF Value €2.62
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Ashler et Manson EBIT?

Ashler et Manson XPAR:MLAEM 80 EBIT is €0.08 Mil as of Dec. 2024. GuruFocus rates XPAR:MLAEM with a GF Score™ of 80/100 and a GF Value™ of €2.62 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Ashler et Manson's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was €0.08 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.08 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ashler et Manson's annualized ROC % for the quarter that ended in Dec. 2024 was 4.13%. Ashler et Manson's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 23.51%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ashler et Manson's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 1.75%.

Ashler et Manson  (XPAR:MLAEM) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ashler et Manson's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=0.087 * ( 1 - 17.72% )/( (1.894 + 1.573)/ 2 )
=0.0715836/1.7335
=4.13 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.075 - 0.178 - ( 0.003 - max(0, 0.178 - 0.677+0.003))
=1.894

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1.803 - 0.22 - ( 0.01 - max(0, 0.22 - 0.426+0.01))
=1.573

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Ashler et Manson's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.079/( ( (0.003 + max(0.484, 0)) + (0.002 + max(0.183, 0)) )/ 2 )
=0.079/( ( 0.487 + 0.185 )/ 2 )
=0.079/0.336
=23.51 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.66 + 0 + 0.002) - (0.178 + 0 + 0)
=0.484

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.399 + 0 + 0.004) - (0.22 + 0 + 0)
=0.183

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ashler et Manson's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=0.079/4.521
=1.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ashler et Manson EBIT Related Terms

Ashler et Manson EBIT Historical Data

* Premium members only.

The historical data trend for Ashler et Manson's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ashler et Manson EBIT Chart

Ashler et Manson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.12 0.14 0.03 0.08

Ashler et Manson Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.12 0.14 0.03 0.08

XPAR:MLAEM vs MRSH, AON, AJG: EBIT Comparison

For the Insurance Brokers subindustry, Ashler et Manson's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ashler et Manson EV-to-EBIT vs Insurance Industry

For the Insurance industry and Financial Services sector, Ashler et Manson's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ashler et Manson's EV-to-EBIT falls into.


XPAR:MLAEM
80GF Score
Ashler et Manson SA XPAR:MLAEM
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ashler et Manson EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €0.08 Mil mean?
Ashler et Manson (XPAR:MLAEM) has a EBIT of €0.08 Mil as of Dec. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Ashler et Manson.
Is Ashler et Manson's EBIT too high?
Ashler et Manson's current EBIT is €0.08 Mil. Overall, Ashler et Manson has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ashler et Manson's EBIT compare to MRSH and AON?
Ashler et Manson's EBIT of €0.08 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Insurance company?
A good EBIT depends on the Insurance industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Ashler et Manson. Ashler et Manson's current EBIT is €0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ashler et Manson stock overvalued right now?
Based on GuruFocus' analysis, Ashler et Manson (XPAR:MLAEM) is currently considered Modestly Overvalued. The stock's GF Value™ is €2.62, compared to a current price of €3.04 — trading 16% above its estimated fair value. The current EBIT is €0.08 Mil. Ashler et Manson's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Ashler et Manson (XPAR:MLAEM), the current EBIT is €0.08 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ashler et Manson (XPAR:MLAEM) Overvalued in 2026?

Based on GuruFocus' analysis, Ashler et Manson stock appears to be overvalued. The current stock price of €3.04 is trading 16% above its estimated GF Value™ of €2.62. GuruFocus considers Ashler et Manson to be Modestly Overvalued.

Key valuation signals for XPAR:MLAEM:

  • EBIT: €0.08 Mil
  • GF Value™: €2.62 vs. price of €3.04 (16% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the XPAR:MLAEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ashler et Manson Business Description

Address 2 Allees d'Orleans, Bordeaux, FRA, 33000
Ashler et Manson SA is a France-based brokerage group in real estate credit and loan insurance sector.
80GF Score

Get the complete analysis for XPAR:MLAEM

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.04
Price
€2.62
GF Value